Patil T - Search Results

1

2020 Innovation-Based Optimism for Lung Cancer Outcomes.

Schenk EL, Patil T, Pacheco J, Bunn PA Jr. Schenk EL, et al. Among authors: patil t. Oncologist. 2021 Mar;26(3):e454-e472. doi: 10.1002/onco.13590. Epub 2020 Dec 20. Oncologist. 2021. PMID: 33179378 Free PMC article. Review.

2

Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status.

Patil T, Aisner DL, Noonan SA, Bunn PA, Purcell WT, Carr LL, Camidge DR, Doebele RC. Patil T, et al. Lung Cancer. 2016 Jun;96:27-32. doi: 10.1016/j.lungcan.2016.03.007. Epub 2016 Mar 26. Lung Cancer. 2016. PMID: 27133746

3

Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung.

Noonan SA, Patil T, Gao D, King GG, Thibault JR, Lu X, Bunn PA, Doebele RC, Purcell WT, Barón AE, Camidge DR. Noonan SA, et al. Among authors: patil t. J Thorac Oncol. 2018 Jan;13(1):134-138. doi: 10.1016/j.jtho.2017.08.005. Epub 2017 Aug 24. J Thorac Oncol. 2018. PMID: 28843358 Free PMC article.

4

The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib.

Patil T, Smith DE, Bunn PA, Aisner DL, Le AT, Hancock M, Purcell WT, Bowles DW, Camidge DR, Doebele RC. Patil T, et al. J Thorac Oncol. 2018 Nov;13(11):1717-1726. doi: 10.1016/j.jtho.2018.07.001. Epub 2018 Jul 5. J Thorac Oncol. 2018. PMID: 29981925 Free PMC article.

5

Miliary Metastases in Non-Small-Cell Lung Cancer.

Patil T, Pacheco JM. Patil T, et al. N Engl J Med. 2018 Nov 15;379(20):1945. doi: 10.1056/NEJMicm1803514. N Engl J Med. 2018. PMID: 30428292 Free article. No abstract available.

6

Epidemiology and treatment trends for primary tracheal squamous cell carcinoma.

Hararah MK, Stokes WA, Oweida A, Patil T, Amini A, Goddard J, Bowles DW, Karam SD. Hararah MK, et al. Among authors: patil t. Laryngoscope. 2020 Feb;130(2):405-412. doi: 10.1002/lary.27994. Epub 2019 Apr 12. Laryngoscope. 2020. PMID: 30977524 Free PMC article.

7

Targeted therapies for ROS1-rearranged non-small cell lung cancer.

Patil T, Simons E, Mushtaq R, Pacheco JM, Doebele RC, Bowles DW. Patil T, et al. Drugs Today (Barc). 2019 Oct;55(10):641-652. doi: 10.1358/dot.2019.55.10.3030646. Drugs Today (Barc). 2019. PMID: 31720561 Review.

8

Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.

Patil T, Mushtaq R, Marsh S, Azelby C, Pujara M, Davies KD, Aisner DL, Purcell WT, Schenk EL, Pacheco JM, Bunn PA, Camidge DR, Doebele RC. Patil T, et al. Clin Lung Cancer. 2020 May;21(3):e191-e204. doi: 10.1016/j.cllc.2019.11.008. Epub 2019 Nov 21. Clin Lung Cancer. 2020. PMID: 31859066 Free PMC article.

9

Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer.

Patil T, Pacheco JM, Dimou A, Purcell WT, Rossi C, Bunn PA, Doebele RC, Camidge DR, Ferrigno L. Patil T, et al. Front Oncol. 2020 Apr 15;10:510. doi: 10.3389/fonc.2020.00510. eCollection 2020. Front Oncol. 2020. PMID: 32351892 Free PMC article.

10

Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis.

Reckamp KL, Patil T, Kirtane K, Rich TA, Espenschied CR, Weipert CM, Raymond VM, Santana-Davila R, Doebele RC, Baik CS. Reckamp KL, et al. Among authors: patil t. Clin Lung Cancer. 2020 Nov;21(6):545-552.e1. doi: 10.1016/j.cllc.2020.06.015. Epub 2020 Jun 20. Clin Lung Cancer. 2020. PMID: 32665165 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

269 results

Search Page